RespiQ
PrivateLast Round
Grant
Jul 11, 2025
Total Funding Raised
$4.69M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
RespiQ operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Grant round in July 2025.
RespiQ is a medical device company that develops AI-enhanced breath analysis sensors for real-time disease diagnosis and management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Medical AI, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RespiQ Comparables
Compare RespiQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breathomix | 88% | |
| Lumetry Diagnostics | 86% | |
| TidalSense | 83% |
For institutional investors. Book with your work email.
RespiQ Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 11, 2025 | ||||
| Grant | Apr 23, 2025 | ||||
| Grant | Nov 20, 2023 | ||||
| Grant | Jul 4, 2023 | ||||
| Debt | Oct 8, 2021 | ||||
Grant | Jul 8, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RespiQ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Eureka Network | Grant |
| Antler | Accelerator, Pre Seed |
| European Innovation Council Fund | Grant |
| Netherlands Enterprise Agency | Grant |
| Women TechEU | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 116% MoM, reaching 2.9K.
- Jul 26, 2026
Monthly visitors grew 122% MoM, from 611 to 1.4K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 30, 2026
Respiq is developing AIMSense with Balthazar, combining machine learning and data infrastructure with Balthazar's platform to improve portable, non-invasive gas sensing for respiratory and gut health, supported by the Dutch MIT R&D Collaboration–AI Grant.
- integrates_withSep 30, 2026
Respiq pairs its machine learning and data infrastructure with Balthazar's platform through AIMSense to accelerate research, optimise sensor performance, and identify molecular patterns in photonic sensing hardware.
For institutional investors. Book with your work email.
RespiQ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RespiQ's valuation, stock price, and market status.
Is RespiQ a public or private company?
RespiQ is a private company.
What is the current stock price of RespiQ?
RespiQ is a private company, so its shares have no public market price. Caplight tracks RespiQ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RespiQ worth (valuation)?
Valuation information for RespiQ is not publicly available.
Can I buy RespiQ stock?
RespiQ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RespiQ's last funding round?
RespiQ's most recent funding round was Grant on July 11, 2025.
Who are the main investors in RespiQ?
Key investors in RespiQ include European Innovation Council Fund, Antler.
Will RespiQ IPO soon?
No public IPO plans have been announced for RespiQ.
How can I track RespiQ secondary market activity?
Caplight tracks bids, offers, and trades in RespiQ's shares on secondary markets.